FDA Clearance of Faster Interpretation Time of Chromogenic MRSASelect™

go back to news archives
Bio-Rad now have FDA clearance for a faster interpretation time of its existing MRSASelect™ test, a chromogenic medium that is used for the rapid screening of MRSA (methicillin-resistant Staphylococcus aureus).

With high sensitivity and specificity as well as rapid and direct identification, the MRSASelect test can now identify MRSA carriers in as little as 18 hours. Bio-Rad received FDA clearance in the U.S. to market its MRSASelect test with the new interpretation time in June. The test was originally introduced in the U.S. in October 2007.

NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Bio-Rad Laboratories View Company Information

Posted on September 16, 2008

bioMerieux 3P CONNECT fully digitalized EM solution
advertisement
Enumeration of TYMC in Water in 48 hours with Diamidex MICA Highlight
advertisement
Maximizing Efficiency With BAMS Cherwell Expert Insights
advertisement
compare products in the buyers directory
advertisement

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS

RMB LOGO

Get all the latest updates on products and services for your microbiology lab in the free weekly rapidmicrobiology newsletter - sign up now!

Contact info

  • Rapid Test Methods Ltd
  • C/O O’Mahony Donnelly Limited (Xeinadin Group), BLDG G West Cork Technology Park, Clonakilty, CORK, Ireland P85 VF62.
  • +[353] 2388 31884
  • info@rapidmicrobiology.com

Submit

rapidmicrobiology

Other sections

© 2001 - 2024 Rapid Test Methods Ltd. All rights reserved.